JBM (Healthcare) Limited (2161 HK) has scheduled a board meeting on 17 November 2025 to consider and approve the interim results for the six months ended 30 September 2025. Plans for an interim dividend, if any, will be reviewed, alongside other business matters. The announcement was issued on 5 November 2025.

The Board is chaired by an executive director and includes additional executive, non-executive, and independent non-executive directors. The interim results and any potential recommendation for a dividend will be published following the meeting, in accordance with regulatory disclosure requirements.